SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-200103
Filing Date
2014-05-15
Accepted
2014-05-15 07:56:24
Documents
3
Period of Report
2014-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d723709d8k.htm 8-K 15042
2 EX-99.1 d723709dex991.htm EX-99.1 58955
3 GRAPHIC g723709g56e40.jpg GRAPHIC 15459
  Complete submission text file 0001193125-14-200103.txt   96579
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 14843889
SIC: 2834 Pharmaceutical Preparations